Public Company News

Meet Coway's Innovative Life Solutions, Including Airmega, at the CES 2022

* Coway introduces the Smart Care Air Mattress and Smart Sleep Solution, combining its latest Sleep and Air Care innovation, for the first time with an interactive experience exclusively at the conference * The exhibit also features the new "Noble Collection," highlighting Coway's impressive ...

2022-01-05 13:54 3274

Antengene to Present at the 40th Annual J.P. Morgan Healthcare Conference

SHANGHAI and HONG KONG, Jan. 5, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncol...

2022-01-05 12:50 4543

IND Approved for Pivotal Clinical Study of HER2 Bispecific Antibody KN026 Combined with Chemotherapy in Gastric Cancer

SUZHOU, China, Jan. 5, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that the IND application for the pivotal clinical trial (KN026-CSP-001) of the anti-HER2 bispecific antibody KN026 combined with che...

2022-01-05 11:49 5343

Black Desert Mobile's Collaboration with Prime Gaming Returns

SEOUL, South Korea, Jan. 5, 2022 /PRNewswire/ -- Pearl Abyss today announced Black Desert Mobile's collaboration with Prime Gaming. Adventurers who are also a member of Amazon Prime can now obtain special in-game rewards during the event period. 

2022-01-05 10:00 3644

KT SAT unveils its new brand of maritime satellite communication targeting South East Asia market

SEOUL, South Korea, Jan. 5, 2022 /PRNewswire/ -- KT SAT(www.ktsat.com ), the leading provider of satellite communication service inSouth Korea unveils its new maritime brand "XWAVE" that stands for the company's vision of expanding the global market toSouth East Asia. The ...

2022-01-05 09:00 8642

Hyundai Motor Unveils Innovative Plug & Drive Robotic Module to Enable Unlimited Mobility of Things at CES 2022

* New Mobility of Things (MoT) concept to enable the movement of traditionally inanimate objects through the company's robotics technology * Plug & Drive (PnD) and Drive & Lift (DnL) modules to provide all-in-one mobility solutions as parts of an unlimited MoT ecosystem * PnD module to provi...

2022-01-05 07:45 4012

Hyundai Motor Shares Vision of New Metamobility Concept, 'Expanding Human Reach' through Robotics & Metaverse at CES 2022

LAS VEGAS and SEOUL, South Korea, Jan. 5, 2022 /PRNewswire/ -- * Hyundai Motor to share its vision for robotics in the real world and metaverse under the theme'Expanding Human Reach' to fulfill unlimited freedom of mobility * Company to pioneer new 'Metamobility' concept, going beyond physic...

2022-01-05 07:00 3715

Fifth Wall Raised $1.1 Billion Across its Funds in 2021

Firm Invested in 25+ New Portfolio Companies, and Celebrated 5 Portfolio Company IPOs LOS ANGELES, Jan. 5, 2022 /PRNewswire/ -- Today, Fifth Wall, the largest venture capital firm focused on technologies for the global real estate industry, announced that it raised more than$1.1 billion across...

2022-01-05 03:39 5123

TCL To Release its First 144Hz Mini LED TV Series in 2022, Raising the Bar for Responsive Video Gaming on Large Screen TVs

HONG KONG, Jan. 4, 2022 /PRNewswire/ -- TCL Electronics (1070.HK), a leading consumer electronics brand, announced during CES 2022 that it will roll out 144Hz Mini LED TVs in 2022 to deliver a more responsive and fluid video gaming experience. The first of a new generation of TV displays, the TCL...

2022-01-04 22:00 5184

TCL Announces New Brand Slogan, 144 Hz Mini LED TVs & All-New Mobile Devices at CES 2022

HONG KONG, Jan. 4, 2022 /PRNewswire/ -- TCL Electronics (1070.HK), a leading consumer electronics brand, held a series of virtual press events today, where its chairperson and senior executives shared the company's latest brand slogan "Inspire Greatness" and business developments. The audience wa...

2022-01-04 22:00 5728

Ubiik Selects Sequans Monarch 2 GM02S Module for Taiwan Power Company's Advanced Metering Infrastructure Deployment

PARIS, Jan. 4, 2022 /PRNewswire/ -- Sequans Communications S.A. (NYSE: SQNS) announced that Ubiik, a leading global Industrial IoT solutions provider with a proven track record in large scale deployments, is using its Monarch 2 GM02S LTE-M/NB-IoT module as a new connectivity solution in Ubiik's r...

2022-01-04 21:00 3882

Quectel Launches New Generation of Flagship Android Smart Module

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Quectel Wireless Solutions, a global supplier of IoT solutions, has announced the launch of the SG865W-WF, a new generation of flagship Android smart module. The module is equipped with Qualcomm's QCS8250 system-on-chip (SoC), which offers powerful performan...

2022-01-04 20:00 5220

Perfect combination of low power and high performance: Infineon introduces the new AIROC(TM) CYW20829 Bluetooth(R) LE system on chip

MUNICH, Jan. 4, 2022 /PRNewswire/ -- Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is launching the AIROC™ CYW20829 Bluetooth® LE system on chip (SoC). The AIROC CYW20829 Bluetooth LE SoC is a Bluetooth 5.3 core spec-compliant device for IoT, smart home and industrial applications. With the ...

2022-01-04 17:05 3536

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

FREMONT, Calif. and CAMBRIDGE, England, Jan. 4, 2022 /PRNewswire/ -- Alamar Biosciences  (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC...

2022-01-04 17:00 3107

Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH

* ASC43F was safe and well tolerated in healthy subjects with no clinically significant study drug related adverse events * Pharmacokinetic parameters of ASC41 and ASC42 from ASC43F are similar to those of ASC41 and ASC42 monotherapy * Phase I trial completed two months after the U.S. IND ap...

2022-01-04 08:30 4621

Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products inAsia, announced today that T...

2022-01-04 08:00 5321

Buybacks of series B shares in AB Electrolux during week 52, 2021

STOCKHOLM, Jan. 4, 2022 /PRNewswire/ -- During the period December 27 – December 30, 2021 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 342,312 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize...

2022-01-04 02:20 3539

New Year's Greetings from Quan Long, Chairman and CEO of Autohome: Unswerving determination in implementing strategic upgrade, Creating a new peak in business growth

HONG KONG, Jan. 3, 2022 /PRNewswire/ -- Since the first launch of "ecosystem" strategy upgrade on 2021 Investor Day in September, Autohome (NYSE: ATHM; HKEX: 2518) steadily implemented various measures and recruited top talent from the Internet and automobile sector. In the New Year's all-staff e...

2022-01-03 20:32 4810

Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads Investment in Xuanzhu Biopharm

HONG KONG, Jan. 3, 2022 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange stock code: 0460) is pleased to announce that, its subsidiary Xuanzhu...

2022-01-03 14:24 8048

Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus

- Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection - ASC11 is ...

2022-01-03 08:30 4896
1 ... 871872873874875876877 ... 904